Nokea
A nurse is reviewing the health record of a client who asks about using Propranolol to treat hypertension. The nurse should recognize which of the following conditions is a contraindication for taking propranolol?
- A. Asthma
- B. Glaucoma
- C. Hypertension
- D. Tachycardia
Correct Answer: A
Rationale: Propranolol is contraindicated in asthma due to risk of bronchoconstriction.
You may also like to solve these questions
A nurse is caring for a client who has Atrial Fibrillation and a new prescription for Dabigatran to prevent development of Thrombosis. Which of the following medications is prescribed concurrently to treat an adverse effect of Dabigatran?
- A. Vitamin k1
- B. Protamine
- C. Omeprazole
- D. Probenecid
Correct Answer: C
Rationale: Omeprazole reduces dabigatran's GI bleeding risk, a common side effect.
Pregnant women should receive the Tdap vaccine:
- A. In the first trimester
- B. Once every 10 years
- C. In the third trimester of every pregnancy
- D. Tdap is contraindicated in pregnancy
Correct Answer: C
Rationale: Tdap in the third trimester protects newborns from pertussis; it's not contraindicated or trimester-specific otherwise.
Which statement is correct regarding glucagon:
- A. Causes hypoglicemia
- B. Haven't affect glucose level in the blood
- C. Has a positive inotroic effect
Correct Answer: C
Rationale: Glucagon has a positive inotropic effect on the heart, increasing contractility, in addition to raising blood glucose levels.
The following drug is used for diabetic coma:
- A. Glibenclamid
- B. Long acting insulin preparations
- C. The rapid and intermediate acting insulin preparations
- D. Metformin
Correct Answer: C
Rationale: Rapid and intermediate-acting insulins are used to quickly correct hyperglycemia in diabetic coma.
Which route of drug administration is most likely to lead to first pass effect?
- A. Sublingual
- B. Oral
- C. Intravenous
- D. Intramuscular
Correct Answer: B
Rationale: Oral administration subjects drugs to the first-pass effect, where they are metabolized by the liver via the portal vein before reaching systemic circulation, reducing bioavailability.